Intestinal Biotech Development

Intestinal Biotech Development (IBD) is a specialized Contract Research Organization (CRO) and biotechnology company focused on digestive health and inflammatory bowel diseases (IBD). Based in Lille, France, the company provides a comprehensive range of preclinical and clinical research services to pharmaceutical and biotech partners, leveraging its deep expertise in gastroenterology. IBD offers validated in vitro and in vivo models, including humanized mice and intestinal organoids, to evaluate the efficacy and safety of new therapeutic candidates. The company is closely associated with the University of Lille and the CHU of Lille, benefiting from a strong academic and clinical network. Its services support the development of treatments for conditions such as Crohn's disease, ulcerative colitis, and irritable bowel syndrome.